Tumor-associated epilepsy.
Tumor-associated epilepsy is an important contributor to morbidity in patients with brain tumors. Proposed pathophysiological mechanisms to explain these effects range from neuronal and glial dysfunction to deranged vascular homeostasis, to ionic and pH changes. Perilesional tissue alterations play a vital role in the generation of tumor-associated seizures. Clinical studies have determined that tumor-associated seizures are usually focal with secondary generalization and often resistant to antiepileptic drugs. Tumor histopathological characteristics and location are independent factors that impact seizure burden. Further understanding of the mechanisms of tumor-associated epilepsy may lead to new types of treatments targeted at perilesional tissue alterations.
Rajneesh
Kiran F
KF
Department of Neurological Surgery, University of California, Irvine, California, USA.
Binder
Devin K
DK
D000927:Anticonvulsants / Q000627:therapeutic use; D001921:Brain / Q000503:physiopathology; D001932:Brain Neoplasms / Q000150:complications* / Q000503:physiopathology*; D004351:Drug Resistance; D004828:Epilepsies, Partial / Q000209:etiology / Q000503:physiopathology; D004827:Epilepsy / Q000188:drug therapy / Q000209:etiology* / Q000503:physiopathology*; D004829:Epilepsy, Generalized / Q000209:etiology / Q000503:physiopathology; D006801:Humans
D000927:Anticonvulsants